Navigation

J&J, AstraZeneca resume trials of COVID-19 vaccines

J&J, AstraZeneca resume trials of COVID-19 vaccines
AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.

Share

Post A Comment:

0 comments:

Leave a comment. Thanks!